Matrix elasticity directs stem cell lineage specification; Tissue cells feel and respond to the stiffness of their substrate; Polymer vesicles; Polymersomes: tough vesicles made from diblock copolymers; Growth factors, matrices, and forces combine and control stem cells; Shape effects of filaments versus spherical particles in flow and drug delivery; Myotubes differentiate optimally on substrates with tissue-like stiffness: pathological implications for soft or stiff microenvironments; Nuclear lamin-A scales with tissue stiffness and enhances matrix-directed differentiation; Substrate compliance versus ligand density in cell on gel responses; Bio-inspired, bioengineered and biomimetic drug delivery carriers; Mesenchymal stem cell perspective: cell biology to clinical progress; Mitotic progression following DNA damage enables pattern recognition within micronuclei; Minimal"" Self"" peptides that inhibit phagocytic clearance and enhance delivery of nanoparticles; Embryonic cardiomyocytes beat best on a matrix with heart-like elasticity: scar-like rigidity inhibits beating; Physical plasticity of the nucleus in stem cell differentiation; Mesenchymal stem cell injection after myocardial infarction improves myocardial compliance; Self-porating polymersomes of PEG–PLA and PEG–PCL: hydrolysis-triggered controlled release vesicles; Molecular weight dependence of polymersome membrane structure, elasticity, and stability; Biodegradable polymersomes loaded with both paclitaxel and doxorubicin permeate and shrink tumors, inducing apoptosis in proportion to accumulated drug; Polymer vesicles in vivo: correlations with PEG molecular weight
